• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参总皂苷在糖尿病状态下调节足细胞 p130Cas。

Ginseng total saponin modulates podocyte p130Cas in diabetic condition.

机构信息

Department of Pediatrics, College of Medicine, Chungbuk National University, Cheongju 361-763, Korea.

出版信息

J Ginseng Res. 2013 Mar;37(1):94-9. doi: 10.5142/jgr.2013.37.94.

DOI:10.5142/jgr.2013.37.94
PMID:23717162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3659616/
Abstract

Proteinuric conditions demonstrate structural and compositional changes of the foot processes and slit diaphragms between podocytes. p130Cas in podocytes serves as an adapter protein anchoring glomerular basement membrane to actin filaments of podocyte cytoskeleton. To investigate the effect of ginseng total saponin (GTS) on the pathologic changes of podocyte p130Cas induced by diabetic conditions, we cultured mouse podocytes under: 1) normal glucose (5 mM, control); 2) high glucose (HG, 30 mM); 3) advanced glycosylation endproducts (AGE)-added; or 4) HG plus AGE-added conditions and treated with GTS. In confocal imaging, p130Cas colocalized with zonula occludens-1 and synaptopodin connecting to F-actin. However, diabetic conditions relocalized p130Cas molecules at perinuclear cytoplasmic area and reduced the intensity of p130Cas. In Western blotting, diabetic conditions, especially HG plus AGE-added condition, decreased cellular p130Cas protein levels at 24 and 48 h. GTS improved such quantitative and qualitative changes. These findings imply that HG and AGE have an influence on the redistribution and amount of p130Cas of podocytes, which can be reversed by GTS.

摘要

蛋白尿状态表明足细胞的足突和裂孔隔膜的结构和组成发生了变化。足细胞中的 p130Cas 作为衔接蛋白,将肾小球基底膜锚定到足细胞细胞骨架的肌动蛋白丝上。为了研究人参总皂苷 (GTS) 对糖尿病条件下足细胞 p130Cas 病理变化的影响,我们在以下条件下培养小鼠足细胞:1)正常葡萄糖(5mM,对照);2)高葡萄糖(HG,30mM);3)晚期糖基化终产物(AGE)添加;或 4)HG 加 AGE 添加条件,并给予 GTS 处理。在共聚焦成像中,p130Cas 与封闭蛋白-1 和突触蛋白共定位,连接到 F-肌动蛋白。然而,糖尿病条件将 p130Cas 分子重新定位到核周细胞质区域,并降低了 p130Cas 的强度。在 Western blot 中,糖尿病条件,特别是 HG 加 AGE 添加条件,在 24 和 48 小时降低了细胞 p130Cas 蛋白水平。GTS 改善了这种定量和定性的变化。这些发现表明,HG 和 AGE 对足细胞 p130Cas 的重分布和数量有影响,GTS 可以逆转这种影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0424/3659616/ef5adac4f761/grosbr-37-94-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0424/3659616/259d8b025383/grosbr-37-94-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0424/3659616/ef5adac4f761/grosbr-37-94-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0424/3659616/259d8b025383/grosbr-37-94-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0424/3659616/ef5adac4f761/grosbr-37-94-g002.jpg

相似文献

1
Ginseng total saponin modulates podocyte p130Cas in diabetic condition.人参总皂苷在糖尿病状态下调节足细胞 p130Cas。
J Ginseng Res. 2013 Mar;37(1):94-9. doi: 10.5142/jgr.2013.37.94.
2
Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts.人参总皂苷可改善高糖和晚期糖基化终产物诱导的足细胞高通透性。
J Korean Med Sci. 2011 Oct;26(10):1316-21. doi: 10.3346/jkms.2011.26.10.1316. Epub 2011 Oct 1.
3
Ginseng total saponin modulates the changes of α-actinin-4 in podocytes induced by diabetic conditions.人参总皂苷调节糖尿病状态下足细胞α-辅肌动蛋白-4 的变化。
J Ginseng Res. 2014 Oct 15;38(4):233-8. doi: 10.1016/j.jgr.2014.05.004. Epub 2014 May 28.
4
Changes of podocyte p130Cas in diabetic conditions.糖尿病状态下足细胞p130Cas的变化
J Nephrol. 2013 Sep-Oct;26(5):870-6. doi: 10.5301/jn.5000261. Epub 2013 Apr 5.
5
Ginseng Total Saponin Attenuates Podocyte Apoptosis Induced by Diabetic Conditions Through the Recovery of CD2-Associated Protein.人参总皂苷通过恢复CD2相关蛋白减轻糖尿病条件诱导的足细胞凋亡。
J Med Food. 2019 Feb;22(2):170-177. doi: 10.1089/jmf.2017.4139. Epub 2019 Jan 2.
6
Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.糖尿病状态通过 PI3-K/Akt 信号通路下调足细胞中 CD2AP 的表达。
Diabetes Metab Res Rev. 2015 Jan;31(1):50-60. doi: 10.1002/dmrr.2562.
7
Puromycin aminonucleoside modulates p130Cas of podocytes.嘌呤霉素氨基核苷调节足细胞的p130Cas。
Korean J Pediatr. 2012 Oct;55(10):371-6. doi: 10.3345/kjp.2012.55.10.371. Epub 2012 Oct 29.
8
High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling.高糖和晚期糖基化终产物通过 PI3-K/Akt 信号通路增加足细胞通透性。
J Mol Med (Berl). 2010 Apr;88(4):391-400. doi: 10.1007/s00109-009-0575-8. Epub 2010 Jan 8.
9
Role of vitamin D in improvement in changes of podocyte P-cadherin/β-catenin complex induced by diabetic conditions.维生素D在改善糖尿病条件诱导的足细胞P-钙黏蛋白/β-连环蛋白复合物变化中的作用。
Iran J Kidney Dis. 2015 May;9(3):194-201.
10
CD2AP and p130Cas localize to different F-actin structures in podocytes.CD2AP和p130Cas定位于足细胞中不同的F-肌动蛋白结构。
Am J Physiol Renal Physiol. 2001 Oct;281(4):F769-77. doi: 10.1152/ajprenal.2001.281.4.F769.

引用本文的文献

1
Review of Ginseng Anti-Diabetic Studies.人参抗糖尿病研究述评。
Molecules. 2019 Dec 9;24(24):4501. doi: 10.3390/molecules24244501.
2
Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase.血管紧张素II通过抑制AMP激活的蛋白激酶来调节足细胞的p130Cas。
J Korean Med Sci. 2016 Apr;31(4):535-41. doi: 10.3346/jkms.2016.31.4.535. Epub 2016 Mar 2.
3
Ginseng total saponin modulates the changes of α-actinin-4 in podocytes induced by diabetic conditions.人参总皂苷调节糖尿病状态下足细胞α-辅肌动蛋白-4 的变化。

本文引用的文献

1
Ginseng in traditional herbal prescriptions.传统草药方剂中的人参。
J Ginseng Res. 2012 Jul;36(3):225-41. doi: 10.5142/jgr.2012.36.3.225.
2
Trends in ginseng research in 2010.2010 年人参研究的趋势。
J Ginseng Res. 2011 Nov;35(4):389-98. doi: 10.5142/jgr.2011.35.4.389.
3
Puromycin aminonucleoside modulates p130Cas of podocytes.嘌呤霉素氨基核苷调节足细胞的p130Cas。
J Ginseng Res. 2014 Oct 15;38(4):233-8. doi: 10.1016/j.jgr.2014.05.004. Epub 2014 May 28.
Korean J Pediatr. 2012 Oct;55(10):371-6. doi: 10.3345/kjp.2012.55.10.371. Epub 2012 Oct 29.
4
Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.Balb/c 背景下整合素 α1/Akita 双敲除小鼠发展出人类糖尿病肾病的晚期特征。
Kidney Int. 2012 Jun;81(11):1086-97. doi: 10.1038/ki.2011.474. Epub 2012 Feb 1.
5
Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts.人参总皂苷可改善高糖和晚期糖基化终产物诱导的足细胞高通透性。
J Korean Med Sci. 2011 Oct;26(10):1316-21. doi: 10.3346/jkms.2011.26.10.1316. Epub 2011 Oct 1.
6
Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats.热加工人参及其活性成分 20(S)-人参皂苷 Rg3 对 2 型糖尿病 Otsuka Long-Evans Tokushima Fatty 大鼠肾脏损伤和功能障碍进展的影响。
Biol Pharm Bull. 2010;33(6):1077-81. doi: 10.1248/bpb.33.1077.
7
Inhibition of podocyte FAK protects against proteinuria and foot process effacement.抑制足细胞 FAK 可预防蛋白尿和足突融合。
J Am Soc Nephrol. 2010 Jul;21(7):1145-56. doi: 10.1681/ASN.2009090991. Epub 2010 Jun 3.
8
[Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].人参皂苷Rg1对糖尿病肾病大鼠肿瘤坏死因子-α和单核细胞趋化蛋白-1表达的影响
Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):466-71.
9
Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via alpha3beta1 integrin upregulation and integrin-linked kinase inhibition.黄芪甲苷通过上调α3β1整合素和抑制整合素连接激酶改善高糖诱导的足细胞黏附功能障碍。
Biochem Pharmacol. 2008 Sep 15;76(6):796-804. doi: 10.1016/j.bcp.2008.06.020. Epub 2008 Jul 4.
10
Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats.20(S)-人参皂苷Rg(3)对链脲佐菌素诱导的大鼠糖尿病肾损伤的治疗潜力
Eur J Pharmacol. 2008 Sep 4;591(1-3):266-72. doi: 10.1016/j.ejphar.2008.06.077. Epub 2008 Jun 27.